Structures by: Schutte-Smith M.
Total: 17
5-Amino-6-nitro-1,10-phenanthroline
C12H8N4O2
IUCrData (2019) 4, 7 x191016
a=14.265(8)Å b=8.060(4)Å c=17.564(9)Å
α=90° β=90° γ=90°
C14H7NO8Re,C14H8NO8Re,2(H2O)
C14H7NO8Re,C14H8NO8Re,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 1 35-46
a=27.848(2)Å b=11.667(3)Å c=19.101(3)Å
α=90° β=100.373(5)° γ=90°
C30H19Cl2NO4PRe
C30H19Cl2NO4PRe
Dalton transactions (Cambridge, England : 2003) (2020) 49, 1 35-46
a=8.6218(12)Å b=11.8120(17)Å c=14.112(2)Å
α=75.594(5)° β=77.006(5)° γ=82.534(5)°
C30H21NO4PRe
C30H21NO4PRe
Dalton transactions (Cambridge, England : 2003) (2020) 49, 1 35-46
a=24.970(2)Å b=9.7010(10)Å c=22.139(2)Å
α=90° β=93.355(5)° γ=90°
C45H35O4P2Re,2(C7H8)
C45H35O4P2Re,2(C7H8)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 1 35-46
a=11.144(2)Å b=14.985(3)Å c=16.723(3)Å
α=66.491(3)° β=72.612(6)° γ=75.940(6)°
C17H15N2O5Re
C17H15N2O5Re
Dalton transactions (Cambridge, England : 2003) (2019) 48, 27 9984-9997
a=8.041(5)Å b=14.996(5)Å c=14.385(5)Å
α=90.000(5)° β=98.333(5)° γ=90.000(5)°
C15H10MnN2O4,CF3O3S
C15H10MnN2O4,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 7 3278-3288
a=10.220(1)Å b=10.514(1)Å c=17.379(2)Å
α=90.000° β=90.604(5)° γ=90.000°
C13H10MnN2O4,CF3O3S
C13H10MnN2O4,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 7 3278-3288
a=10.6620(4)Å b=9.6493(4)Å c=17.1370(7)Å
α=90.000° β=93.195(2)° γ=90.000°
Tetraethylammonium <i>fac</i>-(benzhydroxamato-κ^2^<i>O</i>,<i>O</i>)bromidotricarbonylrhenate(I)
C8H20N,C10H6BrNO5Re
Acta Crystallographica Section C (2019) 75, 4 378-387
a=9.6321(13)Å b=9.8793(11)Å c=12.826(2)Å
α=95.806(10)° β=108.520(11)° γ=112.895(7)°
<i>fac</i>-Aquatricarbonyl(4-oxo-2-phenylchromen-3-olato-\ κ^2^<i>O</i>,<i>O</i>)rhenium(I)—–3-hydroxyflavone (1/1)
C18H11O7Re,C15H10O3
Acta Crystallographica Section C (2019) 75, 4 378-387
a=10.5209(15)Å b=11.9365(17)Å c=12.4455(17)Å
α=108.277(7)° β=102.745(7)° γ=104.252(7)°
3-Hydroxyflavone
C15H10O3
Acta Crystallographica Section C (2019) 75, 4 378-387
a=5.3502(6)Å b=11.3531(14)Å c=18.063(2)Å
α=90° β=90° γ=90°
<i>fac</i>-Hexacarbonyl-1κ^3^<i>C</i>,2κ^3^<i>C</i>-(pyridine-1κ<i>N</i>)[μ-2,2-sulfanediyldi(ethanethiolato)-κ^5^1κ^2^<i>S</i>^1^,<i>S</i>^3^:2κ^3^<i>S</i>^1^,<i>S</i>^2^,<i>S</i>^3^]dirhenium(I)
C15H13NO6Re2S3
Acta Crystallographica Section C (2018) 74, 10 1116-1122
a=9.4460(19)Å b=14.885(3)Å c=15.910(3)Å
α=104.676(5)° β=106.554(5)° γ=104.430(6)°
Tetraethylammonium <i>fac</i>-tris(μ-2-methoxybenzenethiolato-κ^2^<i>S</i>:<i>S</i>)bis[tricarbonylrhenium(I)]
C8H20N,C27H21O9Re2S3
Acta Crystallographica Section C (2018) 74, 10 1116-1122
a=12.7120(5)Å b=17.1050(6)Å c=18.1440(10)Å
α=90° β=91.470(2)° γ=90°
2-(Methylamino)tropone
C8H9N1O1
Acta Crystallographica Section E (2019) 75, 8 1128-1132
a=17.635(5)Å b=7.817(2)Å c=16.718(4)Å
α=90° β=110.639(9)° γ=90°
Tricarbonyl(pyridine-κ<i>N</i>){5-[2-(2,4,6-trimethylphenyl)diazen-1-yl]quinolin-8-olato-κ^2^<i>N</i>^1^,<i>O</i>}rhenium(I)
C26H21N4O4Re
Acta Crystallographica Section C (2013) 69, 12 1467-1471
a=23.723(3)Å b=6.7123(7)Å c=14.8382(17)Å
α=90° β=94.178(4)° γ=90°
{5,7-Bis[2-(2-methylphenyl)diazen-1-yl]quinolin-8-olato-κ^2^<i>N</i>^1^,<i>O</i>}tricarbonyl(pyridine-κ<i>N</i>)rhenium(I)
C31H23N6O4Re
Acta Crystallographica Section C (2013) 69, 12 1467-1471
a=7.9776(6)Å b=11.6818(8)Å c=15.3994(11)Å
α=92.113(4)° β=98.130(3)° γ=92.384(4)°
C13H9N2O5Re
C13H9N2O5Re
Dalton transactions (Cambridge, England : 2003) (2019) 48, 27 9984-9997
a=16.090(5)Å b=6.675(5)Å c=14.052(5)Å
α=90.000° β=112.128(5)° γ=90.000°